Survival probability (%)

Slides:

Advertisements

Similar presentations

Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)

Advertisements

1 MT vs CT: 28 day survival Number at risk CT MT day % Surviving Monotherapy.

The percentage of values for cardiac troponin (cTn)T associated with elevated values for a point-of-care assay with less sensitivity and precision: the.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: A guide to therapeutic decision-making in patients.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of cardiac troponin, CK-MB, and postoperative.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: N-terminal pro brain natriuretic peptide on admission.

American Journal of Kidney Diseases

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,

Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis Riina Kandolin, MD, Jukka Lehtonen, MD, Juhani Airaksinen,

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

Figure 1 Flow diagram displaying the proportions of patients with troponin measurements available from all eligible patients and the resulting study population.

From: Coronary Artery Plaque Burden and Perioperative Cardiac Risk

One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I Cedric Jaeger, MD, Karin Wildi, MD, Raphael Twerenbold,

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Johannes Schmid et al. JACC 2018;71:

Cardiac Troponin.

Diagnostic Algorithms for ACS and High-Sensitivity Troponin

Hospitalizations in the United States Caused by ACS.

Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.

Significance of Elevated Cardiac Troponin T Levels in Critically Ill Patients with Acute Respiratory Disease Vlad C. Vasile, MD, PhD, High-Seng Chai,

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Part I: A Sensible Approach to Sensitive Troponin

Nat. Rev. Cardiol. doi: /nrcardio

Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery Santiago Garcia, MD, Nicholas Marston, MD, Yader Sandoval,

Advancing Acute Coronary Syndrome Assessment:

Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,

Leonardo P. de Carvalho et al. BTS 2018;3:

David F. Katz et al. JACEP 2016;j.jacep

Kevin R. King et al. BTS 2016;1:73-86

Nat. Rev. Cardiol. doi: /nrcardio

American Journal of Kidney Diseases

One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study

Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High- Sensitivity Cardiac Troponin I Yader Sandoval, MD, Stephen W. Smith,

Giuseppe Boriani et al. JACEP 2016;2:

Mohit K. Turagam et al. JACEP 2017;3:

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Mintu P. Turakhia et al. JACEP 2016;2:

Kaplan-Meier curves for overall survival (OS) probability.

Enrollment and Outcomes

David F. Katz et al. JACEP 2017;3:20-28

Neal A. Chatterjee et al. JCHF 2014;2:

High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Combined Use of the Novel Biomarkers High-Sensitivity Troponin T and ST2 for Heart Failure Risk Stratification vs Conventional Assessment Josep Lupón,

Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression Corline Brouwers, Stefan.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.

Kaplan-Meier curves of OS by dose of nivolumab for (A) all patients (n=47), (B) PD-L1-positive patients (n=13) and (C) PD-L1-negative or unknown patients.

Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.

Kaplan-Meier survival curve for unloader brace—Kaplan-Meier survival analysis demonstrated rapid conversion to TKR for the first 12 months, which then.

Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.

Kaplan–Meier survival curve for major adverse cardiac events (MACE): a trend towards superior survival in patients without signs of coronary artery disease.

Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.

Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.

Stavros V. Konstantinides et al. JACC 2017;69:

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial Acute.

Figure 1 Novel markers of increased stroke risk in AF

Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting Francesco Onorati, MD, Marisa De Feo, MD, PhD, Pasquale Mastroroberto,

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

Javier Escaned et al. JCIN 2018;11:

Kaplan-Meier survival curve for all catheterisations.

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.

Kaplan-Meier plot for the prespecified primary endpoint (CARE-HF (A) and the secondary composite endpoint (all-cause mortality and new onset heart failure.

Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.

Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.

Kaplan-Meier survival curves by severity of exacerbations in patients with COPD: (1) no acute exacerbations of COPD; (2) patients with acute exacerbations.

The use of 12 lead electrocardiography and cardiac troponins in the diagnostic evaluation of suspected acute coronary syndrome. *It is unusual to find.

Presentation transcript:

Survival probability (%) Supplemental Fig. 1 Kaplan-Meier curves demonstrating rates of the combined endpoint death/MI over a median follow-up period of 271 days when elevations of either cTnI or hs-cTnT were present. 100 100 95 95 hs-cTnT<99th 90 90 cTnI<99th 85 85 80 80 Survival probability (%) hs-cTnT≥99th 75 75 cTnI≥99th 70 70 Logrank 28,99 p<0.0001 Logrank 32,50 p<0.0001 65 65 60 60 55 55 200 400 600 800 1000 1200 200 400 600 800 1000 1200 Time Time Number at risk Number at risk cTnI<99th: hs-cTnT<99th: 393 319 117 35 14 4 306 252 84 27 11 5 cTnI≥99th: hs-cTnT≥99th: 984 739 266 103 49 9 1 1071 806 299 111 52 8 1 Mueller M et al. - Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome, Clinical Research in Cardiology